Determining how to best allocate orphan disease in portfolios
Prioritizing projects to create a more cohesive portfolio
Balancing high and low risk projects in portfolio design
Who should Attend
Pharmaceutical and Biotechnology representatives, including::
SVPs
CXOs
Senior Directors
VPs
Global Directors
Directors
Senior Managers: Portfolio Management
Heads
Project Management
Portfolio Analysis and Valuation
Strategic Planning
Portfolio Strategy
Business Planning
Pipeline Planning
Past Events
Portfolio Planning and Lifecycle Management for Pharma and Biotech 2013 - 13-14 Nov 2013, Philadelphia Marriott Downtown, Pennsylvania, United States (40058)
Important
Please, check "Portfolio Planning and Lifecycle Management for Pharma and Biotech" official website for possible changes, before making any traveling arrangements
